Displaying 1 - 12 of 19
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Metabolism, Alcohol & Toxicity
6

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
3

Mirum: Meet the Experts in Cholestatic Liver Disease - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
6

Mirum: PSC and IBAT Inhibitors: Can We Apply Our Paediatric Experience in Adult Hepatology? - EASL Congress 2024

View